The Cardiac Arrhythmia Suppression Trial
- 21 December 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 321 (25) , 1754-1756
Abstract
To the Editor: Some proarrhythmia must be expected with the use of all antiarrhythmic drugs. The results of any antiarrhythmic drug trial should therefore be considered in terms of an antiarrhythmia–proarrhythmia equilibrium, with beneficial outcome being an expression of the extent to which antiarrhythmic efficacy exceeds deaths from proarrhythmia. The risk inherent to the study population, provided by mortality figures from the placebo groups, is a major factor in establishing the balance. The Multicenter PostInfarction Research Group study1 and the Cardiac Arrhythmia Pilot Study2 provided meticulous preparation for an interventional trial, but the outcome of the Cardiac Arrhythmia Suppression Trial . . .Keywords
This publication has 9 references indexed in Scilit:
- The Cardiac Arrhythmia Suppression Trial (CAST)New England Journal of Medicine, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- An Interim Perspective on the Removal of Encainide and Flecainide from the Cardiac Arrhythmia Suppression TrialDICP, 1989
- Variability of ventricular premature contractions.Circulation, 1989
- Introduction—Advances in the treatment of supraventricular tachycardiaThe American Journal of Cardiology, 1988
- Spontaneous variability of simple and complex ventricular premature contractions during long time intervals in patients with severe organic heart disease.Circulation, 1988
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainideJACC, 1986
- The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.Circulation, 1984